TIAA CREF INVESTMENT MANAGEMENT LLC - OXFORD IMMUNOTEC GLOBAL PLC ownership

OXFORD IMMUNOTEC GLOBAL PLC's ticker is OXFD and the CUSIP is G6855A103. A total of 73 filers reported holding OXFORD IMMUNOTEC GLOBAL PLC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of OXFORD IMMUNOTEC GLOBAL PLC
ValueSharesWeighting
Q1 2019$3,425,000
+90.1%
198,804
+41.0%
0.00%
+100.0%
Q4 2018$1,802,000
-54.7%
141,021
-42.5%
0.00%0.0%
Q3 2018$3,980,000
+193.1%
245,182
+132.7%
0.00%0.0%
Q2 2018$1,358,000
+26.4%
105,347
+22.1%
0.00%0.0%
Q1 2018$1,074,000
-10.0%
86,292
+1.0%
0.00%0.0%
Q4 2017$1,193,000
-16.3%
85,422
+0.7%
0.00%0.0%
Q3 2017$1,426,000
+11.4%
84,854
+11.5%
0.00%0.0%
Q2 2017$1,280,000
+15.9%
76,094
+6.8%
0.00%0.0%
Q1 2017$1,104,000
+1.8%
71,254
-1.8%
0.00%0.0%
Q4 2016$1,085,000
+29.8%
72,555
+9.0%
0.00%0.0%
Q3 2016$836,000
+31.0%
66,539
-6.2%
0.00%
Q2 2016$638,000
-0.2%
70,909
+10.0%
0.00%
Q1 2016$639,000
-13.8%
64,4530.0%0.00%
-100.0%
Q4 2015$741,000
-14.8%
64,4530.0%0.00%0.0%
Q3 2015$870,000
-2.6%
64,4530.0%0.00%0.0%
Q2 2015$893,000
+24.5%
64,453
+26.6%
0.00%
Q1 2015$717,000
+3.3%
50,9270.0%0.00%
Q4 2014$694,000
-8.6%
50,927
+2.5%
0.00%
-100.0%
Q3 2014$759,000
-9.2%
49,6770.0%0.00%0.0%
Q2 2014$836,000
+160.4%
49,677
+210.9%
0.00%
Q1 2014$321,000
+3.5%
15,9800.0%0.00%
Q4 2013$310,00015,9800.00%
Other shareholders
OXFORD IMMUNOTEC GLOBAL PLC shareholders Q4 2016
NameSharesValueWeighting ↓
Endurant Capital Management LP 1,695,888$15,704,0007.12%
First Light Asset Management, LLC 4,050,040$37,503,0006.40%
Stonepine Capital Management, LLC 374,431$3,467,0003.67%
Penn Capital Management Company, LLC 941,579$8,724,0001.44%
Senvest Management, LLC 1,325,854$12,277,0001.44%
Birchview Capital, LP 170,303$1,577,0001.40%
Grandeur Peak Global Advisors, LLC 1,391,318$12,884,0001.39%
HighMark Wealth Management LLC 114,015$1,055,0001.27%
Consonance Capital Management LP 1,244,460$11,524,0000.86%
Granahan Investment Management 814,431$7,542,0000.41%
View complete list of OXFORD IMMUNOTEC GLOBAL PLC shareholders